Featured Research

from universities, journals, and other organizations

Gene Shut-down May Offer Early Warning Of Chronic Leukemia

Date:
August 7, 2009
Source:
Ohio State University Medical Center
Summary:
A new study shows that certain genes are turned off early in the development of chronic lymphocytic leukemia (CLL), before clinical signs of the disease appear. The study examined cancer cells from CLL patients and from a new strain of mice that develops a very similar disease. The findings suggest that epigenetic alterations might serve as markers for detecting CLL early and for monitoring progression, and that their reversal might delay or prevent progression.

A new study shows that certain genes are turned off early, before clinical signs of the disease appear, in the development of chronic leukemia.

The study, led by researchers at the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, examined cancer cells from patients with chronic lymphocytic leukemia (CLL) and from a new strain of mice that develops a very similar disease.

The findings suggest that changes called epigenetic alterations, which silence a gene's ability to make its protein, might serve as markers for detecting CLL early and for monitoring its progression. They also point to a strategy for treating the disease earlier using drugs that reverse such changes, and further confirm the value of the mouse model for studying CLL causes and treatment, researchers say.

The research revealed that a gene called FOXD3 likely plays a key role in CLL, and that the gene is silenced early, followed by the silencing of other genes.

The findings are published online in the Proceedings of the National Academy of Sciences Early Edition.

"Our data suggest that the silencing of FOXD3 might represent a very early gene involved in the initiation of CLL that we can potentially target for re-expression with specific drugs," says study leader Dr. John C. Byrd, professor of internal medicine, director of the hematologic malignancies program at the James Cancer Hospital and Solove Research Institute and a CLL specialist. "Next, we need to learn whether therapy to reverse this silencing can delay or prevent CLL progression."

An estimated 15,500 Americans are expected to develop CLL in 2009, and about 4,400 people will die of the disease. The malignancy usually strikes people aged 50 or older, causing white blood cells called B lymphocytes to proliferate. This can lead to severe anemia and dangerous viral, bacterial and fungal infections. Average survival is eight to 12 years from diagnosis.

The animal model, called the TCL1 transgenic mouse, was developed by Ohio State cancer researcher Dr. Carlo M. Croce and a group of colleagues in 2002. An earlier study by Byrd and his laboratory showed that the disease in the mouse has many of the same molecular and genetic features as human CLL, responds to drugs used to treat the disease and develops drug resistance, as CLL patients often do.

"Data from this new study demonstrate a strong similarity in gene silencing patterns in the mouse leukemia and in human CLL, suggesting that the changes in the mice mimic critical changes in different stages of the human disease," says Byrd, who worked closely on the study with first author and graduate student Shih-Shih Chen, co-senior author Christoph Plass at the German Cancer Research Center in Heidelberg, and other colleagues.

"We know that human CLL involves the silencing of a number of genes, but we can look at human CLL only after patients develop the disease," he says. "This mouse model now allows us to look at events leading up to the disease and perhaps identify markers for early disease detection and the testing of new therapies."

Funding from the National Cancer Institute, the Leukemia and Lymphoma Society, The D. Warren Brown Foundation and the Thompson family supported this research. Byrd is the D. Warren Brown Professor of Leukemia Research at Ohio State and a Leukemia and Lymphoma Society clinical scholar.


Story Source:

The above story is based on materials provided by Ohio State University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University Medical Center. "Gene Shut-down May Offer Early Warning Of Chronic Leukemia." ScienceDaily. ScienceDaily, 7 August 2009. <www.sciencedaily.com/releases/2009/08/090805164919.htm>.
Ohio State University Medical Center. (2009, August 7). Gene Shut-down May Offer Early Warning Of Chronic Leukemia. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2009/08/090805164919.htm
Ohio State University Medical Center. "Gene Shut-down May Offer Early Warning Of Chronic Leukemia." ScienceDaily. www.sciencedaily.com/releases/2009/08/090805164919.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins